Tempus AI (NASDAQ:TEM) Trading Down 9.5% - Time to Sell?

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report)'s stock price traded down 9.5% on Tuesday . The stock traded as low as $45.25 and last traded at $45.15. 4,582,990 shares changed hands during mid-day trading, a decline of 8% from the average session volume of 4,957,588 shares. The stock had previously closed at $49.87.

Analyst Ratings Changes

Several research firms have recently issued reports on TEM. Needham & Company LLC boosted their target price on Tempus AI from $56.00 to $70.00 and gave the stock a "buy" rating in a research report on Tuesday, February 25th. Wolfe Research cut shares of Tempus AI from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 26th. Bank of America increased their target price on shares of Tempus AI from $54.00 to $60.00 and gave the stock a "neutral" rating in a report on Monday, March 3rd. William Blair reissued a "market perform" rating on shares of Tempus AI in a report on Tuesday, February 25th. Finally, Piper Sandler lowered their price objective on shares of Tempus AI from $70.00 to $55.00 and set a "neutral" rating for the company in a research report on Tuesday, March 4th. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $61.18.

Tempus AI Stock Up 6.9 %

The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The firm has a 50-day moving average of $56.07 and a 200 day moving average of $51.45.

Remove Ads

Insider Activity at Tempus AI

In other Tempus AI news, COO Ryan Fukushima sold 20,000 shares of the firm's stock in a transaction on Tuesday, January 7th. The stock was sold at an average price of $39.61, for a total transaction of $792,200.00. Following the completion of the sale, the chief operating officer now owns 982,442 shares of the company's stock, valued at $38,914,527.62. This trade represents a 2.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, major shareholder Bradley A. Keywell sold 170,720 shares of the company's stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $35.45, for a total transaction of $6,052,024.00. Following the completion of the transaction, the insider now owns 15,993,729 shares in the company, valued at approximately $566,977,693.05. This represents a 1.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 5,598,969 shares of company stock worth $317,194,162.

Institutional Investors Weigh In On Tempus AI

Several hedge funds have recently bought and sold shares of the stock. Operose Advisors LLC acquired a new position in shares of Tempus AI in the fourth quarter valued at approximately $25,000. First Horizon Advisors Inc. bought a new stake in Tempus AI in the 3rd quarter valued at $30,000. Farther Finance Advisors LLC acquired a new position in Tempus AI in the 4th quarter valued at $34,000. Prestige Wealth Management Group LLC grew its holdings in Tempus AI by 910.4% in the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock valued at $36,000 after buying an additional 965 shares in the last quarter. Finally, NewEdge Advisors LLC bought a new position in Tempus AI during the 4th quarter worth $49,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.